Integrin Receptor Antagonist [EPC] class drugs

3 results
  • entyvio - vedolizumab injection, powder, lyophilized, for solution

    (Vedolizumab)
    Takeda Pharmaceuticals America, Inc.
    Entyvio treats moderately to severely active ulcerative colitis and Crohn's disease in adults.
  • tysabri - natalizumab injection

    (Natalizumab)
    Biogen Inc.
    TYSABRI treats relapsing forms of multiple sclerosis (clinically isolated syndrome, relapsing-remitting, and active secondary progressive disease) in adults, and induces and maintains remission in adults with moderately to severely active Crohn's disease unresponsive to conventional therapies or TNF-α inhibitors.